Direct versus indirect comparisons: A summary of the evidence

No abstract is available for this paper.

• Publication year

  2008

• Venue

  International Journal of Technology Assessment in Health Care

• Publication date

  2008-04-01

• Fields of study

  Medicine, Political Science, Psychology

• Identifiers
  DOI 10.1017/S0266462308080240PMID 18400120
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cochrane Handbook for Systematic Reviews of Interventions

  2010cited by this paper
• A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.

  2007cited by this paper
• A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.

  2006cited by this paper
• Indirect comparisons: the mesh and mess of clinical trials.

  2006influential reference
• Lessons from and cautions about noninferiority and equivalence randomized trials.

  2006cited by this paper
• Simultaneous comparison of multiple treatments: combining direct and indirect evidence

  2005cited by this paper
• Indirect comparisons of competing interventions.

  2005influential reference
• Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.

  2005cited by this paper
• Combination of direct and indirect evidence in mixed treatment comparisons

  2004cited by this paper
• An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.

  2003cited by this paper
• Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

  2003cited by this paper
• Network meta‐analysis for indirect treatment comparisons

  2002influential reference
• Acute Efficacy of Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder Including Effects of Baseline Insomnia

  2002cited by this paper
• Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.

  2002cited by this paper
• Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.

  2002cited by this paper
• Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.

  2001cited by this paper
• Claims of Equivalence in Medical Research: Are They Supported by the Evidence?

  2000cited by this paper
• Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.

  2000cited by this paper
• A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients.

  2000cited by this paper
• Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.

  2000cited by this paper
• Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia

  2000cited by this paper
• Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery.

  2000influential reference
• A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients

  1999cited by this paper
• Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.

  1999cited by this paper
• A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.

  1999cited by this paper
• Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France.

  1998cited by this paper
• Efficacy and tolerability of venlafaxine and fluoxetine in outpatients with major depression

  1998cited by this paper
• Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.

  1998cited by this paper
• Efficacy and Tolerability of Once-Daily Venlafaxine Extended Release (XR) in Outpatients With Major Depression

  1997cited by this paper
• The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials.

  1997cited by this paper
• Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes.

  1997cited by this paper
• A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.

  1997cited by this paper
• Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.

  1997cited by this paper
• Once-Daily Venlafaxine Extended Release (XR) and Venlafaxine Immediate Release (IR) in Outpatients with Major Depression

  1997cited by this paper
• A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of major depression

  1997cited by this paper
• A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients.

  1996cited by this paper
• A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.

  1995cited by this paper
• A controlled comparison of sertraline and fluoxetine in acute and continuation treatment of major depression

  1995cited by this paper
• Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study.

  1993cited by this paper
• Venlafaxine in depressed outpatients.

  1991cited by this paper
• Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression.

  1990cited by this paper
• Sertraline, a selective inhibitor of serotonin uptake, for the treatment of outpatients with major depressive disorder.

  1988cited by this paper
• Bmc Medical Research Methodology Open Access the Transitive Fallacy for Randomized Trials: If a Bests B and B Bests C in Separate Trials, Is a Better than C?

  year unknowncited by this paper

• Risk of Bias in Network Meta-Analysis (RoB NMA) tool

  2025cites this paper
• Response to Kumar et al

  2025cites this paper
• Economic evaluation of three domestic bevacizumab biosimilars and the original bevacizumab for treating nonsquamous non-small cell lung cancer in china: a cost-effectiveness analysis

  2025cites this paper
• Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review

  2024cites this paper
• Network meta-analysis of CAR T-Cell therapy for the treatment of 3L+ R/R LBCL after using published comparative studies

  2024cites this paper
• Detecting synthetic population bias using a spatially-oriented framework and independent validation data

  2024cites this paper
• Twenty years of network meta‐analysis: Continuing controversies and recent developments

  2024cites this paper
• Comparative efficacy of vericiguat to sacubitril/valsartan for patients with heart failure reduced ejection fraction: Systematic review and network meta-analysis.

  2024cites this paper
• Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non–small cell lung cancer: a modelling approach

  2023cites this paper
• Is Network Meta-analysis a Revolutionary Statistical Tool for Improving the Reliability of Clinical Trial Results? A Brief Overview and Emerging Issues Arising

  2023cites this paper
• Pharmacological treatment of neuropsychiatric symptoms of dementia: a network meta-analysis protocol

  2020cites this paper
• Health Technology Assessment in Japan: Policy, Pharmacoeconomic Methods and Guidelines, Value, and Beyond

  2019cites this paper
• Intermediate Level Methods

  2019cites this paper
• Comparison of mHealth and Face-to-Face Interventions for Smoking Cessation Among People Living With HIV: Meta-Analysis

  2019cites this paper
• Towards personalising treatment: a systematic review and meta-analysis of face-to-face efficacy moderators of cognitive-behavioral therapy and interpersonal psychotherapy for major depressive disorder

  2019cites this paper
• The Use of Metaanalysis in Pharmacoepidemiology

  2019cites this paper
• STATISTICAL AND GRAPHICAL EVIDENCE SYNTHESIS METHODS IN HEALTH TECHNOLOGY ASSESSMENT

  2016cites this paper
• GetReal in network meta‐analysis: a review of the methodology

  2016cites this paper
• A Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons

  2016cites this paper
• Kerndisziplinen von HTA

  2015cites this paper
• Aliskiren/amlodipine vs. aliskiren/hydrochlorothiazide in hypertension: indirect meta-analysis of trials comparing the two combinations vs. monotherapy.

  2014cites this paper
• Draft Guidelines for Evaluating the Clinical Effectiveness of Health Technologies in Ireland July 2014 Safer Better Care

  2014cites this paper
• Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.

  2014cites this paper
• [Introduction to the indirect meta-analyses].

  2014cites this paper
• Economic Evaluations of Targeted Therapy and Risk-Stratified Treatment Approaches in Multiple Myeloma

  2014cites this paper
• Characteristics of Networks of Interventions: A Description of a Database of 186 Published Networks

  2014cites this paper
• Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland

  2014influential citation
• Efficacy of Varenicline and Nortriptyline in Smoking Cessation : Indirect Comparison of Randomized Controlled Trials

  2014cites this paper
• The Use of Meta‐analysis in Pharmacoepidemiology

  2013cites this paper
• Efficacy of Anti-Leishmania Therapy in Visceral Leishmaniasis among HIV Infected Patients: A Systematic Review with Indirect Comparison

  2013cites this paper
• Review The efficacy and tolerability of perampanel and other recently approved anti-epileptic drugs for the treatment of refractory partial onset seizure: a systematic review and Bayesian network meta-analysis

  2013cites this paper
• Assessing key assumptions of network meta‐analysis: a review of methods

  2013cites this paper
• An indirect comparison of everolimus versus sorafenib in metastatic renal cell carcinoma – a flawed analysis and a problematic response

  2013cites this paper
• The efficacy and tolerability of perampanel and other recently approved anti-epileptic drugs for the treatment of refractory partial onset seizure: a systematic review and Bayesian network meta-analysis

  2013cites this paper
• Hierarchical Bayesian methods for multiple outcomes in mixed treatment comparisons

  2013cites this paper
• Relative effectiveness assessment of pharmaceuticals: similarities and differences in 29 jurisdictions.

  2012cites this paper
• Systematic Review and Adjusted Indirect Comparison Meta-Analysis of Oral Anticoagulants in Atrial Fibrillation

  2012cites this paper
• Methods for the Drug Effectiveness Review Project

  2012cites this paper
• Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons

  2012cites this paper
• Decision making, impulsivity, and addictions: Do Parkinson's disease patients jump to conclusions?

  2012cites this paper
• Novel anticancer agents for multiple myeloma: a review of the evidence for their therapeutic and economic value

  2012cites this paper
• Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies

  2012cites this paper
• Diseño y rea Lización De eva Luaciones económicas a través De moDeLos ana Líticos De Decisión

  2012cites this paper
• DISEÑO Y REALIZACIÓN DE EVALUACIONES ECONÓMICAS A TRAVÉS DE MODELOS ANALÍTICOS DE DECISIÓN

  2012cites this paper
• Análisis de minimización de costes y análisis coste-consecuencia

  2012cites this paper
• Some methodological points to consider when performing systematic reviews in comparative effectiveness research

  2012cites this paper
• effectiveness research Some methodological points to consider when performing systematic reviews in comparative

  2012cites this paper
• Guidelines for Evaluating the Clinical Effectiveness of Health Technologies in Ireland

  2011cites this paper
• Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept

  2011cites this paper
• Can Soccer Predictions Boost the Use of Indirect Comparison to Assess the Safety Of Drugs

  2011cites this paper
• An indirect comparison of bevacizumab plus cisplatin‐gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first‐line non‐squamous non‐small cell lung cancer in East Asia

  2011cites this paper
• Bayesian approaches for multiple treatment comparisons of drugs for urgency urinary incontinence are more informative than traditional frequentist statistical approaches

  2011cites this paper
• Economic evaluation of everolimus versus sorafenib for the treatment of metastatic renal cell carcinoma after failure of first-line sunitinib.

  2011cites this paper
• An adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples

  2011cites this paper
• Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study

  2011cites this paper
• Network meta-analysis of randomised controlled trials: direct and indirect treatment comparisons.

  2011cites this paper
• Using Indirect Evidence to Determine the Comparative Effectiveness of Prescription Drugs: Do Benefits Outweigh Risks?

  2011cites this paper
• The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis.

  2010cites this paper
• Frequency of Treatment-EffectModification Affecting Indirect Comparisons

  2010cites this paper
• Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers

  2010cites this paper
• Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics

  2010cites this paper
• [Relevance of clinical trials for the decision-making process within the bodies of the self-government].

  2010cites this paper
• Femoral Nerve Block Improves Analgesia Outcomes after Total Knee Arthroplasty: A Meta-analysis of Randomized Controlled Trials

  2010cites this paper
• Meta-analysis of randomized controlled trials on the treatment of pulmonary arterial hypertension.

  2010cites this paper
• Cost-utility analysis of rufinamide versus topiramate and lamotrigine for the treatment of children with Lennox-Gastaut Syndrome in the United Kingdom.

  2010cites this paper
• [Requirements on evidence for system-level decision making regarding the adoption of medical services into the Statutory Health Insurance (SHI) catalogue].

  2010cites this paper
• Bedeutung von klinischen Studien für die Entscheidungsfindung in den Gremien der Selbstverwaltung

  2010cites this paper
• Real medical benefit assessed by indirect comparison.

  2009cites this paper
• Bénéfice médical réel estimé par comparaisons indirectes

  2009influential citation
• Methodological Guideline for Quantitative Evidence Synthesis: Direct and Indirect Comparisons

  year unknowncites this paper